Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 3691 AL 3705

Cross-disease genetic and epigenetic architecture of the MOBP locus shows convergence in ALS-PSP

Fodder K, Murthy M, de Silva R, Raj T, Farrell K, Humphrey J, Bettencourt C.

bioRxiv [Preprint]. 2026 Mar 27:2026.03.25.714147. doi: 10.64898/2026.03.25.714147.

Microglial Lag3 Drives α-Synuclein-induced Neurotoxic Activated (A1) Astrocytes and Neurodegeneration

Yang X, Kumbhar R, Seo BA, Ha S, Hinkle JT, Wang N, Li S, Niu L, Liu H, Stanciu N, Chen R, Kimura Y, Xu E, Cheng F, Kang SU, Ying M, Ko HS, Dawson VL, Dawson T, Mao X.

bioRxiv [Preprint]. 2026 Jan 6:2026.01.06.697996. doi: 10.64898/2026.01.06.697996.

LRRK2 regulates ArfGAP1 membrane localization, activity and neuronal toxicity via phosphorylation within its lipid-sensing ALPS2 motif

Shariful Islam M, Cóppola-Segovia V, Musso A, Moore DJ.

bioRxiv [Preprint]. 2026 Jan 13:2026.01.12.699049. doi: 10.64898/2026.01.12.699049.

Synergy Feedback Control Predicts Walking Across Multiple Cycles

Williams S, Li G, Fregly BJ.

bioRxiv [Preprint]. 2026 Mar 4:2026.03.02.709098. doi: 10.64898/2026.03.02.709098.

Lipid Messengers: Mechanisms and Clinical Applications of Exosomal Lipids in Neurodegenerative Diseases

Zhao Y, Pan M, He S, Zhou X.

Mol Neurobiol. 2026 Mar 14;63(1):499. doi: 10.1007/s12035-026-05794-z.

Unraveling the role of non-coding RNAs in Parkinson's disease: Molecular mechanisms and therapeutic insights

Tang P, Jing Z, Tong Z, Peng X, Tong J, Peng Y.

Int J Biochem Cell Biol. 2026 Apr 30;197-198:106963. doi: 10.1016/j.biocel.2026.106963. Online ahead of print.

The Interplay Between Nurr1 and Mitochondrial Biogenesis: Implications for Neurodegenerative Therapy

Kaur S, Mannan A, Singh TG.

Mol Neurobiol. 2026 Jan 19;63(1):372. doi: 10.1007/s12035-025-05633-7.

Unveiling the Potential of Flavonoids in the Regulation of Parkinson's Disease: Special Focus on Quercetin

Singh NK, Solanki K.

J Biochem Mol Toxicol. 2026 Jan;40(1):e70656. doi: 10.1002/jbt.70656.

Potential Synergistic Roles of Ketogenic Diet and Stem Cell Therapy in Parkinson's Disease: A Narrative Review

Sindurakar P, Gorantla VR, Ponnoth D.

Cureus. 2026 Feb 9;18(2):e103304. doi: 10.7759/cureus.103304. eCollection 2026 Feb.

Instrumental assessment of Sit-to-Stand in Parkinson's disease: a scoping review

Trucco M, Ditella R, Dhimitriadhi A, Occhetto B, Ballesio M, Job M, Testa M.

J Neuroeng Rehabil. 2026 May 19. doi: 10.1186/s12984-026-02023-5. Online ahead of print.

Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR-Cas systems

Singh RP, Maity P, Jaiswal C.

Neurochem Int. 2026 Jun;196:106149. doi: 10.1016/j.neuint.2026.106149. Epub 2026 Mar 27.

Appropriate use recommendations for digital technology in cognitive telerehabilitation for people living with Parkinson's disease

Moon S, Leroi I, Kletzel S, Foster ER, Gross M, Heyn P, Hirsch M, Sivaramakrishnan A, van Wegen EEH, Devos H.

Disabil Rehabil Assist Technol. 2026 Apr 15:1-14. doi: 10.1080/17483107.2026.2653063. Online ahead of print.

Clinical Utility of GBA Genotyping Prior to Deep Brain Stimulation: A Narrative Review

Rački V, Lasić S, Ðerke F, Belančić A, Sošić M.

Genes (Basel). 2026 Jan 6;17(1):69. doi: 10.3390/genes17010069.

Dose-Response Relationship of Virtual Reality Training in Parkinson's Disease: A Meta-Analysis of Overall Motor Function, Functional Mobility, and Balance Confidence

Xie L Doctor, Dai J Doctor.

Arch Phys Med Rehabil. 2026 Mar 10:S0003-9993(26)00570-8. doi: 10.1016/j.apmr.2026.02.490. Online ahead of print.

The Brain-Gut Axis in Parkinson's Disease Pathology

Ozkaya KS, Browning KN.

Compr Physiol. 2026 Apr;16(2):e70137. doi: 10.1002/cph4.70137.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias